Active Filter(s):
Details:
The partnership highlight the product line dealing with CD34+ cells and Humanized mouse models, both firms use the framework of collaborative business development to tackle competition and efficiency of research-grade stem cells.
Lead Product(s): Trans HSC (CD34+)
Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed
Highest Development Status: Preclinical Product Type: Large molecule
Partner/Sponsor/Collaborator: L2P Research
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership January 23, 2020